Concepcion Segura
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
ATP Bioluminescence Assay To Evaluate Antibiotic Combinations against Extensively Drug-Resistant (XDR) Pseudomonas aeruginosa.
Journal: Microbiology spectrum
Published: July 25, 2022
Risk Factors for Mortality among Patients with Pseudomonas aeruginosa Bloodstream Infections: What Is the Influence of XDR Phenotype on Outcomes?
Journal: Journal of clinical medicine
Published: January 11, 2020
Statement of the Spanish Society of Allergology and Clinical Immunology on Provocation Tests With Aspirin/Nonsteroidal Anti-inflammatory Drugs.
Journal: Journal of investigational allergology & clinical immunology
Published: September 19, 2019
Colistin plus meropenem combination is synergistic in vitro against extensively drug-resistant Pseudomonas aeruginosa, including high-risk clones.
Journal: Journal of global antimicrobial resistance
Published: January 07, 2019
Impact of an antimicrobial stewardship program on urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
Journal: Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia
Published: March 10, 2018
Evaluation of Ceftolozane-Tazobactam in Combination with Meropenem against Pseudomonas aeruginosa Sequence Type 175 in a Hollow-Fiber Infection Model.
Journal: Antimicrobial agents and chemotherapy
Published: January 08, 2018
Erratum for del Barrio-Tofiño et al., "Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain".
Journal: Antimicrobial agents and chemotherapy
Published: December 23, 2017
Genomics and Susceptibility Profiles of Extensively Drug-Resistant Pseudomonas aeruginosa Isolates from Spain.
Journal: Antimicrobial agents and chemotherapy
Published: August 02, 2017
First Description of blaNDM-7 Carried on an IncX4 Plasmid in Escherichia coli ST679 Isolated in Spain.
Journal: Microbial drug resistance (Larchmont, N.Y.)
Published: June 27, 2017
Validation of a colistin plasma concentration breakpoint as a predictor of nephrotoxicity in patients treated with colistin methanesulfonate.
Journal: International journal of antimicrobial agents
Published: May 09, 2016
Impact of colistin plasma levels on the clinical outcome of patients with infections caused by extremely drug-resistant Pseudomonas aeruginosa.
Journal: BMC infectious diseases
Published: April 20, 2016
Last Updated: 09/26/2026